Literature DB >> 25450379

Type I interferon-mediated immune response against influenza A virus is attenuated in the absence of p53.

Zixiang Zhu1, Yifan Yang2, Jianchao Wei2, Donghua Shao2, Zixue Shi2, Beibei Li2, Ke Liu2, Yafeng Qiu2, Haixue Zheng3, Zhiyong Ma4.   

Abstract

Influenza A virus (IAV) infection induces secretion of type I interferon (IFN) and activation of p53, which play essential roles in the host defense against tumor development and viral infection. In this study, we knocked down p53 expression by RNA interference. The expression levels of IFN-stimulated genes (ISGs) including IFN regulatory factor (IRF) 5, IRF9, ISG15, ISG20, guanylate-binding protein 1, retinoic acid-inducible gene-I and 2'-5'-oligoadenylate synthetase 1 were significantly attenuated in response to IAV infection and IFN-α stimulation in p53-knockdown cells. This attenuated expression of ISGs was associated with enhanced replication of IAV. Pretreatment of p53-knockdown cells with IFN-α failed to inhibit IAV replication, indicating impaired antiviral activity. These findings indicate that p53 plays an essential role in the enhancement of the type I IFN-mediated immune response against IAV infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral immune response; Influenza A virus; Interferon-stimulated genes; Type I interferon; p53

Mesh:

Substances:

Year:  2014        PMID: 25450379     DOI: 10.1016/j.bbrc.2014.10.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death.

Authors:  Ruan F V Medrano; Aline Hunger; João P P Catani; Bryan E Strauss
Journal:  Oncoimmunology       Date:  2017-05-19       Impact factor: 8.110

2.  Basal Level p53 Suppresses Antiviral Immunity against Foot-and-Mouth Disease Virus.

Authors:  Tianliang Zhang; Haotai Chen; Xinsheng Liu; Linlin Qi; Xin Gao; Kailing Wang; Kaishen Yao; Jie Zhang; Yuefeng Sun; Yongguang Zhang; Run Wu
Journal:  Viruses       Date:  2019-08-07       Impact factor: 5.048

Review 3.  ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review.

Authors:  Mengdi Zhang; Jingxian Li; Haiyan Yan; Jun Huang; Fangwei Wang; Ting Liu; Linghui Zeng; Fangfang Zhou
Journal:  Front Cell Dev Biol       Date:  2021-11-25

Review 4.  p53 and the Viral Connection: Back into the Future .

Authors:  Ronit Aloni-Grinstein; Meital Charni-Natan; Hilla Solomon; Varda Rotter
Journal:  Cancers (Basel)       Date:  2018-06-04       Impact factor: 6.639

Review 5.  P53 in the impaired lungs.

Authors:  Mohammad A Uddin; Nektarios Barabutis
Journal:  DNA Repair (Amst)       Date:  2020-08-19

6.  p53 promotes ZDHHC1-mediated IFITM3 palmitoylation to inhibit Japanese encephalitis virus replication.

Authors:  Xin Wang; Zhuanchang Wu; Yuming Li; Yifan Yang; Changguang Xiao; Xiqian Liu; Xiao Xiang; Jianchao Wei; Donghua Shao; Ke Liu; Xufang Deng; Jiaqiang Wu; Yafeng Qiu; Beibei Li; Zhiyong Ma
Journal:  PLoS Pathog       Date:  2020-10-27       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.